Greenlight Capital Re’s Earnings: A Preview

Greenlight Capital Re (NASDAQ:GLRE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Greenlight Capital Re will report an earnings per share (EPS) of $0.45.

Greenlight Capital Re (NASDAQ:GLRE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here’s what investors need to know before the announcement.

Analysts estimate that Greenlight Capital Re will report an earnings per share (EPS) of $0.45.

Greenlight Capital Re bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.42, which was followed by a 5.45% increase in the share price the next day.

Here’s a look at Greenlight Capital Re’s past performance and the resulting price change:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.25 0.90 -0.75
EPS Actual -0.17 0.71 -0.42 0.02
Price Change % 5.45% -1.9% -1.49% -1.15%

Stock Performance

Shares of Greenlight Capital Re were trading at $7.19 as of July 29. Over the last 52-week period, shares are down 17.59%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Greenlight Capital Re visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Earnings Preview: Xenon Pharmaceuticals

Xenon Pharmaceuticals (NASDAQ:XENE) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Xenon Pharmaceuticals will report an earnings per share (EPS) of $-0.52.

XENE

Read More

What’s Going On With CrowdStrike Stock Today?

CrowdStrike Holdings Inc (NASDAQ: CRWD) shares are trading lower Tuesday afternoon ahead of the company's earnings report due after the bell. CrowdStrike is scheduled to report first-quarter earnings results for fiscal 2025 after the market close. Analysts expect EPS of 90 cents and revenue totaling $904.67 million for the quarter, according to Benzinga Pro.

CRWD